Related Experiment Video
Updated: Jul 19, 2026
07:01
Induction and Testing of Hypoxia in Cell Culture
Published on: August 12, 2011
Baffled by bafilomycin: an anticancer agent that induces hypoxia-inducible factor-1alpha expression
1Vascular Biology Program, Institute for Cell Engineering, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Molecular Pharmacology
|September 27, 2006
Summary
Bafilomycin, a vacuolar ATPase inhibitor, shows anticancer effects by inducing hypoxia-inducible factor (HIF) 1alpha and p21(CIP1). This surprising result suggests a novel therapeutic mechanism for cancer treatment.
Area of Science:
- Molecular Pharmacology
- Cancer Biology
- Cell Cycle Regulation
Background:
- Vacuolar ATPase (V-ATPase) inhibitors, like bafilomycin, are explored for anticancer properties.
- Hypoxia-inducible factor 1-alpha (HIF-1alpha) is typically linked to tumor growth and poor patient outcomes.
- Cyclin-dependent kinase inhibitor p21(CIP1) plays a role in cell cycle arrest.
Purpose of the Study:
- To investigate the anticancer effects of bafilomycin.
- To elucidate the molecular mechanisms underlying bafilomycin's impact on cancer cells.
- To examine the role of HIF-1alpha and p21(CIP1) in bafilomycin's action.
Main Methods:
- Treatment of cancer cells with bafilomycin.
- Analysis of cell cycle progression.
- Measurement of gene expression, including HIF-1alpha and p21(CIP1).
Main Results:
- Bafilomycin inhibits cancer cell cycle progression and tumor growth.
- Bafilomycin induces the expression of HIF-1alpha and p21(CIP1).
- The induced HIF-1alpha expression specifically upregulates p21(CIP1) without promoting other tumor-promoting genes.
Conclusions:
- Bafilomycin exhibits anticancer activity through a novel mechanism involving HIF-1alpha and p21(CIP1).
- This study challenges the conventional view of HIF-1alpha's role in cancer, highlighting context-dependent effects.
- Bafilomycin represents a potential therapeutic agent for cancer, warranting further investigation.
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
01:23Hypoxia
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...